Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. (Q54049140)
scientific article
Language:
Current Data About Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome.
(P31) (Q13442814)
(P248)
(P698) 8383934
(P813) Thursday, May 24, 2018
(P854) http://europepmc.org/abstract/MED/8383934

(P50) (Q6834090)
(P1545) 9
(P1932) M Saag
(P248)
(P698) 8383934
(P813) Thursday, May 24, 2018
(P854) http://europepmc.org/abstract/MED/8383934

(P304) 610-616
(P248)
(P698) 8383934
(P813) Thursday, May 24, 2018
(P854) http://europepmc.org/abstract/MED/8383934

(P407) (Q1860)

(P433) 8
(P248)
(P698) 8383934
(P813) Thursday, May 24, 2018
(P854) http://europepmc.org/abstract/MED/8383934

(P478) 118
(P248)
(P698) 8383934
(P813) Thursday, May 24, 2018
(P854) http://europepmc.org/abstract/MED/8383934

(P577) Thursday, April 1, 1993
(P248)
(P698) 8383934
(P813) Thursday, May 24, 2018
(P854) http://europepmc.org/abstract/MED/8383934

(P921) (Q181600)

(Q627625)
(P887)

(P1433) (Q564416)
(P248)
(P698) 8383934
(P813) Thursday, May 24, 2018
(P854) http://europepmc.org/abstract/MED/8383934

(P1476) "Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome." (language: en)
(P248)
(P698) 8383934
(P813) Thursday, May 24, 2018
(P854) http://europepmc.org/abstract/MED/8383934

(P2093) J Wheat
(P1545) 1
(P248)
(P698) 8383934
(P813) Thursday, May 24, 2018
(P854) http://europepmc.org/abstract/MED/8383934

R Hafner
(P1545) 2
(P248)
(P698) 8383934
(P813) Thursday, May 24, 2018
(P854) http://europepmc.org/abstract/MED/8383934

M Wulfsohn
(P1545) 3
(P248)
(P698) 8383934
(P813) Thursday, May 24, 2018
(P854) http://europepmc.org/abstract/MED/8383934

P Spencer
(P1545) 4
(P248)
(P698) 8383934
(P813) Thursday, May 24, 2018
(P854) http://europepmc.org/abstract/MED/8383934

K Squires
(P1545) 5
(P248)
(P698) 8383934
(P813) Thursday, May 24, 2018
(P854) http://europepmc.org/abstract/MED/8383934

W Powderly
(P1545) 6
(P248)
(P698) 8383934
(P813) Thursday, May 24, 2018
(P854) http://europepmc.org/abstract/MED/8383934

B Wong
(P1545) 7
(P248)
(P698) 8383934
(P813) Thursday, May 24, 2018
(P854) http://europepmc.org/abstract/MED/8383934

M Rinaldi
(P1545) 8
(P248)
(P698) 8383934
(P813) Thursday, May 24, 2018
(P854) http://europepmc.org/abstract/MED/8383934

R Hamill
(P1545) 10
(P248)
(P698) 8383934
(P813) Thursday, May 24, 2018
(P854) http://europepmc.org/abstract/MED/8383934

R Murphy
(P1545) 11
(P248)
(P698) 8383934
(P813) Thursday, May 24, 2018
(P854) http://europepmc.org/abstract/MED/8383934

P Connolly-Stringfield
(P1545) 12
(P248)
(P698) 8383934
(P813) Thursday, May 24, 2018
(P854) http://europepmc.org/abstract/MED/8383934

N Briggs
(P1545) 13
(P248)
(P698) 8383934
(P813) Thursday, May 24, 2018
(P854) http://europepmc.org/abstract/MED/8383934

S Owens
(P1545) 14
(P248)
(P698) 8383934
(P813) Thursday, May 24, 2018
(P854) http://europepmc.org/abstract/MED/8383934

National Institute of Allergy and Infectious Diseases Clinical Trials and Mycoses Study Group Collaborators
(P1545) 15
(P248)
(P698) 8383934
(P813) Thursday, May 24, 2018
(P854) http://europepmc.org/abstract/MED/8383934

other details
description scientific article

External Links
(P356) 10.7326/0003-4819-118-8-199304150-00006
(P698) 8383934